SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-626558
Filing Date
2016-06-20
Accepted
2016-06-20 17:06:04
Documents
7
Period of Report
2016-08-04
Effectiveness Date
2016-06-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A d82610ddef14a.htm DEF 14A 1702522
2 GRAPHIC g82610g21i52.jpg GRAPHIC 159803
3 GRAPHIC g82610g21k48.jpg GRAPHIC 146517
4 GRAPHIC g82610g45s07.jpg GRAPHIC 37546
5 GRAPHIC g82610g48l96.jpg GRAPHIC 78730
6 GRAPHIC g82610pcpg1.jpg GRAPHIC 177426
7 GRAPHIC g82610pcpg2.jpg GRAPHIC 177090
  Complete submission text file 0001193125-16-626558.txt   2774959
Mailing Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4
Business Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33500 | Film No.: 161722730
SIC: 2834 Pharmaceutical Preparations